4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-004341
President and Chief Executive sold 5,821 shares at $8.20 ($47,729)
- President and Chief Executive acquired 97,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2023-01-19 | Grant or award | +97,500 | 182,628 | D | ||
| Curran Terrie President and Chief Executive | 2023-01-20 | Sale | −5,821 | $8.20 | $47,729 | 176,807 | D |
| Derivatives | |||||||
| Curran Terrie President and Chief Executive | 2023-01-19 | Grant or award · Stock Option (Right to Buy) | +162,500 | 162,500 | D | ||
| Open-market sales · 5,821 sh · avg $8.20 · $47,729 | |||||||
Loading xslF345X03/doc4.xml…